What evidence is available that rivaroxaban passes into breast milk?

Animal data indicate that rivaroxaban (Xarelto) is secreted into milk; safety and efficacy in breast-feeding women are unestablished, so Xarelto is contraindicated during breast-feeding and a decision must be made whether to discontinue breast-feeding or discontinue/abstain from therapy.